T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2020.00276
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Cancer Immunotherapies Targeting Tumor-Associated Regulatory T Cells

OncoTargets and Therapy
OncologyPharmacology
2019English

Monoclonal Antibodies Targeting CD38 in Hematological Malignancies and Beyond

Immunological Reviews
AllergyImmunology
2016English

Adoptive T-Cell Therapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors

International Journal of Hematology
Hematology
2013English

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2008English

Landscape of Tumor Antigens in T Cell Immunotherapy

Journal of Immunology
AllergyImmunology
2015English

Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2011English

Novel Immunotherapies in Lymphoid Malignancies

Nature Reviews Clinical Oncology
Oncology
2015English

CAR T Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological Malignancies

AAPS Journal
Pharmaceutical Science
2019English

Studies on Tumor Cell Functions of T Cell Malignancies (5 Cases)

Japanese Journal of Clinical Immunology
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy